Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
52.45
-0.71 (-1.34%)
Feb 21, 2025, 4:00 PM EST - Market closed
Mirum Pharmaceuticals Employees
Mirum Pharmaceuticals had 264 employees as of December 31, 2023. The number of employees increased by 68 or 34.69% compared to the previous year.
Employees
264
Change (1Y)
68
Growth (1Y)
34.69%
Revenue / Employee
$1,162,985
Profits / Employee
-$378,072
Market Cap
2.52B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
MIRM News
- 1 day ago - US FDA approves Mirum Pharma's genetic disorder drug - Reuters
- 3 days ago - Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025 - Business Wire
- 11 days ago - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates - Business Wire
- 6 weeks ago - Top 5 Commercial Biotech Buyout Candidates: Mirum Pharmaceuticals (No. 3) - Seeking Alpha
- 6 weeks ago - Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Mirum Pharma: Buy At Dips For Volixibat Potential - Seeking Alpha
- 3 months ago - Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD's The Liver Meeting - Business Wire